Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme

被引:69
作者
Combs, SE
Gutwein, S
Thilmann, C
Huber, P
Debus, J
Schulz-Ertner, D
机构
[1] Univ Heidelberg, Dept Radiat Oncol, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr DKFZ, Dept Radiat Oncol, Heidelberg, Germany
关键词
overall survival; recurrent glioblastoma multiforme; stereotactic fractionated radiotherapy;
D O I
10.1007/s11060-004-2463-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. To assess the feasibility, efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent glioblastoma multiforme. Patients and Methods. From January 1995 to July 2003, 53 patients with histologically proven glioblastoma multiforme were treated at recurrence with fractionated stereotactic radiation therapy. A median dose of 36 Gy using a median fractionation of 5 x 2 Gy/week was applied. Results. Median overall survival was 21 months, and median overall survival from the time point of re-irradiation was 8 months. The median time interval between primary and secondary radiation therapy was 10 months. In this patient population, no variables predicting longer overall survival could be determined. However, neurosurgical resection at relapse was associated with increased survival after re-irradiation (p=0.04), but left progression-free survival unaltered. Treatment was well-tolerated and no severe toxicities developed. Conclusion. Stereotactically guided fractionated re-irradiation is a safe and effective treatment modality in selected cases of recurring glioblastoma multiforme. Since this is not a randomized study, further evaluation in larger patient collectives is warranted. Also, based on recent results of radiochemotherapy in the treatment of primary glioblastoma multiforme, concomitant chemotherapy at relapse might be considered in the future.
引用
收藏
页码:167 / 171
页数:5
相关论文
共 30 条
[1]   Reirradiation of primary CNS tumors [J].
Bauman, GS ;
Sneed, PK ;
Wara, WM ;
Stalpers, LJA ;
Chang, SM ;
McDermott, MW ;
Gutin, PH ;
Larson, DA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (02) :433-441
[2]   A MEDICAL-RESEARCH-COUNCIL TRIAL OF 2 RADIOTHERAPY DOSES IN THE TREATMENT OF GRADE-3 AND GRADE-4 ASTROCYTOMA [J].
BLEEHEN, NM ;
STENNING, SP .
BRITISH JOURNAL OF CANCER, 1991, 64 (04) :769-774
[3]   Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma [J].
Bower, M ;
Newlands, ES ;
Bleehen, NM ;
Brada, M ;
Begent, RJH ;
Calvert, H ;
Colquhoun, I ;
Lewis, P ;
Brampton, MH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) :484-488
[4]   Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse [J].
Brada, M ;
Hoang-Xuan, K ;
Rampling, R ;
Dietrich, PY ;
Dirix, LY ;
Macdonald, D ;
Heimans, JJ ;
Zonnenberg, BA ;
Bravo-Marques, JM ;
Henriksson, R ;
Stupp, R ;
Yue, N ;
Bruner, J ;
Dugan, M ;
Rao, S ;
Zaknoen, S .
ANNALS OF ONCOLOGY, 2001, 12 (02) :259-266
[5]   Survival Analysis Part II: Multivariate data analysis - an introduction to concepts and methods [J].
Bradburn, MJ ;
Clark, TG ;
Love, SB ;
Altman, DG .
BRITISH JOURNAL OF CANCER, 2003, 89 (03) :431-436
[6]   Salvage chemotherapy with taxol for recurrent anaplastic astrocytomas [J].
Chamberlain, MC ;
Kormanik, P .
JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (01) :71-78
[7]   Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas [J].
Cho, KH ;
Hall, WA ;
Gerbi, BJ ;
Higgins, PD ;
McGuire, WA ;
Clark, HB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (05) :1133-1141
[8]   Survival analysis part I: Basic concepts and first analyses [J].
Clark, TG ;
Bradburn, MJ ;
Love, SB ;
Altman, DG .
BRITISH JOURNAL OF CANCER, 2003, 89 (02) :232-238
[9]  
Combs SE, 2005, STRAHLENTHER ONKOL, V181, P372, DOI 10.1007/s00066-005-1359-x
[10]   RESULTS OF A RANDOMIZED TRIAL COMPARING BCNU PLUS RADIOTHERAPY, STREPTOZOTOCIN PLUS RADIOTHERAPY, BCNU PLUS HYPERFRACTIONATED RADIOTHERAPY, AND BCNU FOLLOWING MISONIDAZOLE PLUS RADIOTHERAPY IN THE POSTOPERATIVE TREATMENT OF MALIGNANT GLIOMA [J].
DEUTSCH, M ;
GREEN, SB ;
STRIKE, TA ;
BURGER, PC ;
ROBERTSON, JT ;
SELKER, RG ;
SHAPIRO, WR ;
MEALEY, J ;
RANSOHOFF, J ;
PAOLETTI, P ;
SMITH, KR ;
ODOM, GL ;
HUNT, WE ;
YOUNG, B ;
ALEXANDER, E ;
WALKER, MD ;
PISTENMAA, DA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (06) :1389-1396